This report addresses whether full-text clinical studies, systematic reviews, and clinical practice guidelines and position statements support the use of the Monarch eTNS [external trigeminal nerve stimulation] System (NeuroSigma Inc.) for the treatment of attention-deficit/hyperactivity disorder (ADHD) in children.

If you have a Hayes login, click here to view the full report on the Knowledge Center.